Areti‐Maria Vasilogianni

Manchester Academic Health Science Centre — United Kingdom

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

8h-index177citations12works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(6), Drug Transport and Resistance Mechanisms(5), Advanced Proteomics Techniques and Applications(3), Mass Spectrometry Techniques and Applications(3), Metabolomics and Mass Spectrometry Studies(3)

Publications12 total

The quest to define cancer-specific systems parameters for personalized dosing in oncology
Expert Opinion on Drug Metabolism & Toxicology·2025· 1 cited
Complementarity of two proteomic data analysis tools in the identification of drug-metabolising enzymes and transporters in human liver
Molecular Omics·2023· 2 citedOpen Access
Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis
Frontiers in Oncology·2023· 5 citedOpen Access
Proteomic quantification of perturbation to pharmacokinetic target proteins in liver disease
Journal of Proteomics·2022· 15 citedOpen Access
Quantitative Proteomics of Hepatic Drug‐Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis
Clinical Pharmacology & Therapeutics·2022· 22 citedOpen Access
A family of QconCATs (Quantification conCATemers) for the quantification of human pharmacological target proteins
Journal of Proteomics·2022· 10 citedOpen Access
Label-Free but Still Constrained: Assessment of Global Proteomic Strategies for the Quantification of Hepatic Enzymes and Transporters
Drug Metabolism and Disposition·2022· 7 citedOpen Access
Proteomics of colorectal cancer liver metastasis: A quantitative focus on drug elimination and pharmacodynamics effects
British Journal of Clinical Pharmacology·2021· 21 citedOpen Access
Hepatic Scaling Factors for In Vitro–In Vivo Extrapolation of Metabolic Drug Clearance in Patients with Colorectal Cancer with Liver Metastasis
Drug Metabolism and Disposition·2021· 15 citedOpen Access
Mass spectrometry‐based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin
FEBS Letters·2020· 31 citedOpen Access
Toxicity assessment and comparison of the land snail's Cornu aspersum responses against CuO nanoparticles and ZnO nanoparticles
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology·2020· 18 cited
Quantitative mass spectrometry-based proteomics in the era of model-informed drug development: Applications in translational pharmacology and recommendations for best practice
Pharmacology & Therapeutics·2019· 30 citedOpen Access

Frequent Co-authors

Zubida M. Al‐Majdoub(11), Brahim Achour(11), Amin Rostami‐Hodjegan(11), Jill Barber(11), Sarah Alrubia(6), Eman El‐Khateeb(5), Sheila Annie Peters(5), Narciso Couto(4), Martyn Howard(2), Daniel Scotcher(2), Yasmine Elmorsi(1), Noura A. Alohali(1), Sibylle Neuhoff(1), Lutz Schmitt(1), Konstantinos Feidantsis(1), Stavros Kalogiannis(1), Angela Marinoni(1), Christina Gkanatsiou(1), Georgia Kastrinaki(1), C. Dendrinou-Samara(1)